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Summary 
 
Metabolome analyses are a suite of analytical approaches that enable us to capture changes in the metabolome (small 
molecular weight components, typically<1500 Da) in biological systems. Mass spectrometry (MS) has been widely used 
for this purpose. The key challenge here is to be able to capture changes in a reproducible and reliant manner that is 
representative of the events that take place in vivo. Typically, the analysis is carried out in vitro, by isolating the system 
and extracting the metabolome. MS based approaches enable us to capture metabolomic changes with high sensitivity and 
resolution. When developing the technique for different biological systems, there are similarities in challenges and 
differences that are specific to the system under investigation.  Here we review some of the challenges in capturing 
quantitative changes in the metabolome with MS based approaches, primarily in microbial and mammalian systems. 
 
 
1. Introduction  
 Post-genome science is characterised by the parallel analyses of gene products at the level of the transcripts, 
proteins and metabolites, and forms the basis of Systems Biology. Characterising metabolomes is central to developing a 
systems level understanding of cellular function [1-3]. Capturing changes at the level of the metabolome provides a 
window of opportunity to develop an understanding of the biological phenotype observed, and the link between the 
genotype and the expressed phenotype, in a biological system. Metabolomes represent the final level RI ³-RPLF´
information that can potentially tell us how an organism organises itself in expressing the phenotype that is observable.  
  
The field of metabolome analyses is currently developing rapidly for the study of several biological systems 
including microbial [4-6], plant [7-9] and mammalian systems [10-12]. However its broad deployment to biotechnology 
and clinical research and practice is not yet as wide spread as desired due to several challenges in the quantitative 
metabolomics workflow that remain. Absolute quantification of metabolite concentrations, in the true sense, is difficult to 
achieve in non-targeted metabolomics, and most quantitative measurements are relative changes and are at best semi-
quantitative (however for ease of reference we use tKH ZRUG ³TXDQWLWDWLYH´ LQ WKH UHVW RI WKH DUWLFOH. Since the key 
objective in most metabolomics workflows lies in capturing changes in the metabolome in response to perturbations to 
the biological system monitored, relative quantifications usually serve the purpose.  This can be achieved with the help of 
external and/or internal standards (ESs and ISs).  
 
 Most comprehensive metabolomics workflows employ either nuclear magnetic resonance (NMR) or mass 
spectrometry (MS) based detections. MS has the advantage of higher speed, versatility, and high degree of specificity and 
sensitivity, which are desired characteristics in quantitative workflows. Given the diversity of chemical characterisations 
required, only a partial coverage of the total metabolome can be expected to be captured with current technology, 
although it is often impossible to define what the full metabolome would be in a given organism under a given 
physiological state. The specificity and sensitivity can be enhanced by hyphenation of MS with high resolution separation 
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techniques such as gas chromatography (GC), liquid chromatography (LC) or capillary electrophoresis (CE). Whilst 
enhancing data resolution, these hyphenation techniques bring in additional challenges. In addition to analytical 
challenges, challenges also exist in controlling the biological variability, sample processing steps (quenching, extraction 
and derivatization), selection of normalisation and quantitative standards, data processing steps and quality control (QC) 
and validation of all the steps involved in metabolomics pipeline. Overall, in any quantitative MS based metabolomics, 
MS is just one part of the integrated workflow, failure or compromise in any step of the overall workflow will invalidate 
the entire assay. In this review we assess some of these challenges involved in MS based quantitative metabolomics with 
a focus on application to microbial and mammalian systems. 
 
2. Approaches in metabolomics 
 The two orthogonal approaches used in metabolomics are targeted and non-targeted metabolomics. Targeted 
metabolomics involves hypothesis driven experiments and are characterised by obtaining the quantitative data on a 
predefined set of metabolites with a high level of precision and accuracy. This absolute quantification approach requires 
not only specialised extraction protocols but also specialised separation and detection techniques in order to identify and 
quantify a subset of pathway-specific metabolites. Non-targeted metabolomics studies are applied as a hypothesis 
generation strategy and are characterised by simultaneous qualitative and quantitative measurement of a large number of 
metabolites in samples. Non-targeted metabolomics utilises relative quantification of metabolites, where metabolites 
spectral patterns and intensities are recorded, statistically compared and used to identify the relevant spectral features that 
distinguish sample class, and has the potential to provide a panoramic view covering both primary and secondary 
metabolites. However the wide diversity of metabolites in terms of their physicochemical properties presents a major 
challenge in comprehensively profiling them in a biological system. Hence analyses of metabolome requires an integrated 
workflow and a number of different approaches. The approaches commonly used in metabolomics are listed in 
Supplementary Table 1, which aims at investigating subsets of the metabolome depending on the biological question. 
 
3. Challenges in MS based quantitative metabolomics  
 Standardisation of the quantitative MS based metabolomics workflow is essential in deriving accurate and 
meaningful biological interpretations. To explore the great potential of metabolomics, it is essential to first address the 
challenges involved prior to sampling, during sample preparation and processing and in data acquisition and analysis.  
 
3.1 Challenges prior to sampling 
3.1.1 Biological variability  
 In any quantitative analysis, biological variability can introduce systematic errors. The final reported 
concentration of metabolites primarily needs to relate to the viable cell population.  Viable cells (biovolume) contribute to 
the metabolome that is relevant and therefore represents the proportion of biomass of interest for intracellular metabolite 
quantification. It is important to ensure this population is sufficiently high in the samples to make appropriate 
interpretations. In addition, it must be noted that the sampled population provides only a statistical average of the overall 
population metabolic status, as the cells may not all be in the same physiological state. It is therefore important to take 
note of these in assessing the metabolome for quantitative changes. In cases where single cell metabolomics can provide 
valuable information these variations can be accounted for, but the techniques for these are still under development [13]. 
Optical density and/or cell dry weight (CDW) is commonly used as the reference to obtain biomass specific concentration 
data under the assumption that impact of cell viability and population heterogeneity is negligibly small, thereby 
introducing systematic errors right from the beginning. Moreover these errors should be kept constant in any follow up 
experiments in order to make the data comparable. In addition, variances resulting from media preparation, inoculum 
densities or pre-cultivation almost always exceed analytical variance. Therefore a minimum of five biological replicates is 
recommended [14] to account for such variances. 
 
3.1.2 Normalisation strategy 
 As we are interested in changes in metabolite concentration due to biological events and not due to non-
biological factors, sample normalisation in quantitative metabolomics is crucial in order to minimise the effect of sample 
variations. Sample normalisation in metabolomics is much more complicated compared to that of genomics and 
proteomics due to the wide physicochemical diversity of metabolites and this is an understated issue within quantitative 
metabolomics that can have a significant influence on the interpreted results. To date consideration of total metabolite 
concentration or an equivalent metric is not common practice, as it is in proteomics.  
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 Two strategies are commonly used in metabolome normalisation namely pre-acquisition and/or post-acquisition. 
In the pre-acquisition strategy, the extracted metabolome is normalised to a metric such as biomass that would be 
expected to have an even influence over all the metabolites extracted for a given sample. In the post-acquisition strategy, 
individual metabolite signals are normalised for different samples to a metric that is uniformly applicable to all samples 
post-acquisition, such as the total ion signal intensity of a chromatogram [15].  In MS, varying degrees of ionisation 
efficiencies and ion suppression effects contribute to signal intensities, which often result in non-uniform response for 
individual metabolites. Hence it can be argued that more accurate quantitative results can be obtained with pre-acquisition 
normalisation. Moreover, this strategy can also be used to determine the optimal sample injection amount for MS in order 
to improve the detection of low concentration metabolites. In contrast, post-acquisition strategy is relatively convenient 
and simpler to perform, as it does not require additional experimental set up as required in the pre-acquisition strategy. 
The selection of appropriate normalisation strategy is largely dependent on various factors such as the type of biological 
system under investigation, required normalisation accuracy, convenience, speed and cost, and in some cases use of both 
strategies may be needed. 
 
 In cellular metabolomics, variation in seeding densities and/or sampling strategies requires normalisation of cell 
extract by cell counting. The haemocytometer is widely used for this purpose in suspension cultures. In case of adherent 
cell cultures, cells are detached from their surfaces and harvested either by trypsinization or cell scraping. Both methods 
often result in loss of cells and changes in metabolic pattern [16], thereby impairing the accuracy of normalisation by cell 
counts. In the case of microbial cells, determining cell counts may be difficult due to their small sizes, and colony 
forming units (CFU) may be used instead. Alternatively, normalisation to OD600 values could provide a reliable way for 
quantitative analysis [17]. However, both methods require an additional experimental set up, making it cumbersome for 
quantitative metabolomics that is also difficult to apply for adherent cell cultures.  
 
 Other conventional methods include, normalisation to dry cell weight (DCW), total cellular content of proteins, 
ATP and/or DNA. Normalisation to DCW is not ideal, as the method is time consuming, requires large number of 
samples and introduces relatively large amount of weighing errors [18]. Normalisation to protein content using BCA or 
Bradford assay has been widely used, but a better correlation between cell numbers with cellular DNA content than 
protein content has been shown in some cases [19]. Both approaches require separate experiment and can be time 
consuming. The classical method for cell proliferation/viability studies include CFU, however the overall method is not 
precise and optimal for slow growing cells. Alternatively, ATP is a key central metabolite to all live cells and intracellular 
concentration of ATP is fairly constant in living cells while rapid loss of ATP occurs from dead cells. Hence ATP 
quantification using bioluminescence is an attractive solution to conventional CFU enumeration. Moreover, ATP 
estimation using bioluminescence method can be more rapid, reliable, sensitive, time saving and less expensive compared 
to conventional methods. 
 
 An alternative method for normalisation involves use of specific metabolite biomarkers [20]. However, it is 
important to note that, these biomarkers may be specific to the cell lines under investigation and need to be selectively 
identified. Normalisation of each peak area to the sum of all peak areas has been evaluated [21] as an alternative to 
normalisation to cell count, where the authors reported good linear correlation with this method. Authors also 
recommended that, this method should only be applied when the difference in concentration between two comparative 
samples is less than two fold, as otherwise the number of false detections would increase to over 10%. Determining the 
UV absorbance of the sample solution at a specific wavelength as a measure of the total concentration of solute is another 
concept of sample normalisation [15]. This method can be more representative of the overall sample composition, 
independent of the biological matrix and is performed prior to MS acquisition. Moreover, the method is advantageous to 
cellular metabolomic studies as it does not require an extra procedure and can be used to correct the concentration 
variations introduced during the sample preparation steps. This method was further developed [22] into a dansylation 
metabolite assay, where absorbance of labelled metabolite was measured using simple microplate reader instead of 
expensive LC-UV systems. Authors have shown a good linear relationship between the UV absorbance values and the 
cell suspension volume or the protein content.  
 
3.2 Challenges in sample preparation  
 The metabolites of interest can be lost during sample preparation steps, which require careful evaluation and 
validation using a set of internal standards to enable accurate quantification.  
 
3.2.1 Use of internal standards (ISs) 
 Commonly used stable isotope labelled ISs include metabolites labelled with 2H, 13C, 15N and 18O. They possess 
similar chemical properties to that of the non-labelled metabolites, which result in their partitioning with the associated 
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metabolite throughout the analytical workflow. In addition, they also compensate for any ion suppression effects by 
matching the ionisation properties of the analyte. This eliminates both sample preparation and instrumental bias and can 
be used for quantification of metabolites. However, it is important to have sufficient mass difference between the labelled 
metabolite standard and the associated non-labelled metabolite from the sample in order to avoid isotopic interferences 
from the naturally occurring metabolite in the quantification of the reference compound [23]. Due to a wide diversity of 
metabolites many of which are still uncharacterised, use of isotope-labelled ISs for individual metabolites is not a 
practical approach. Moreover, availability and expense will have a significant role in its employment. In cases where 
there are batch to batch variations resulting in absence or very low concentration of some metabolites of interest in the 
isotope cell extracts, the use of such ISs might not be valid. In such cases, the use of labelled derivatization reagent might 
be useful as demonstrated in the past for the absolute quantification of amino and non-amino organic acids in urine and 
serum samples [24]. 
 
 Use of a pooled QC sample has been advocated in some cases [23]. This involves generation of the calibration 
model by analysing the different dilutions of a pooled sample, which can then be used for relative quantification of 
metabolites. This method can only be applied to samples where matrix effects are minimal. It provides a good way to 
monitor detector drift, inertness of the analytical column and in calculating the repeatability and precision of response for 
all metabolites. In the absence of ISs, quantification can be done by spiking or the method of standard additions to the 
matrix. This method eliminates any chemical or physical bias between the standards and the samples, however increases 
the number of sample determinations required for each sample [25]. Alternatively ESs can be run independently, where 
the instrumental response to standard concentration is measured to generate the response curve, which can then be used to 
calculate the metabolite concentration. This method can only be applied to samples which require minimum preparation 
and have high degree of reproducibility and good recovery. This method is very good in detecting or correcting for 
detector drift and in controlling the inertness of the analytical platform. If the sample matrix is not well characterised, this 
method can have bias from matrix effects. Normalisation using optimal selection of multiple ISs (NOMIS) uses the 
variability information from multiple ISs across multiple samples to find the optimal normalisation factor for individual 
detected metabolite.  
 
 Any error by the analyst in weighing, diluting, dispensing or dissolving ISs will be propagated and compromise 
the integrity of overall assay. Hence it is important to incorporate the selected ISs at the earliest stage possible such as 
during quenching or extraction steps. Moreover, it is important to add the optimal amount of IS, as adding too much or 
too little of IS can increase the variance in the overall assay. The ideal concentration of IS is recommended [25] to be 
threefold in excess to that of the expected metabolite concentration.  
 
3.2.2 Quenching  
 The high turnover rate of intracellular metabolites requires rapid sampling and instantaneous quenching of 
enzyme activities under mild conditions in order to retain a valid snapshot of the metabolic processes. Quenching with 
60% v/v cold methanol at -40°C has been used widely in the past for various biological systems. However, potential 
problems connected to leakage of intracellular metabolites with this method have been reported [26, 27]. Various 
alternatives to cold methanol quenching such as filter culture methodology, fast filtration, mass balance approach and use 
of alternative quenching solvents have been evaluated. However, all suggested alternatives [28] have advantages and 
disadvantages and more importantly cannot be directly applied to a given organism, without prior evaluation. In addition, 
these alternatives have also been shown to add difficulties in the overall metabolomics workflow. 
 
 To minimise metabolite leakage with cold methanol quenching, additives that will buffer the effect and minimise 
osmotic shock have been suggested [29]. Commonly employed buffer additives involve methanol supplemented with 
either HEPES, AMBIC, tricine or NaCl. Influence of these additives in preserving the membrane integrity and therefore 
in minimising metabolite leakage is well studied (see supplementary Table 2). The concentration of methanol and the 
quenching temperature [30] can also have an influence on metabolite leakage.  
 
 To minimise the influence of exo-metabolome on intracellular metabolite extraction, cells must be rapidly 
separated from the culture medium after quenching following centrifugation or fast filtration. To minimise carry-over 
effects, it is often essential to introduce an additional washing step in the workflow. Inclusion of a washing step for 
adherent cultures is easier as it can be performed rapidly prior to quenching. However, influence of washing solutions on 
metabolite leakage requires careful evaluation prior to their implementation. In contrast, introducing a washing step in the 
case of suspension cultures is not ideal as it needs to be performed prior to quenching which will result in delaying the 
quenching time frame.  
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3.2.3 Extraction 
 Due to the diverse physicochemical properties of metabolites, the identification of an optimal extraction solvent 
to quantitatively extract all intracellular metabolites represents a major challenge in metabolomics. In the past, strong 
acids or alkali were commonly employed as routine methods for the extraction of acid and alkali stable compounds from 
animal and plant tissues and microorganisms. Later use of these solvents were limited as they result in lower number of 
data points with poor reproducibility (as most of the metabolites are unstable at low or high pH conditions) compared to 
mild extraction solvents [31]. Moreover, these methods are time consuming, as they require neutralisation of the sample 
at later stage. Recently, the compatibility between the extraction solvent and the subsequent analytical platform is gaining 
more attention and reveals a trend towards selection of more mild extraction conditions such as use of cold organic 
solvents (see supplementary Table 3). However, the selection of an optimal extraction solvent and method seems to be 
based on the metabolite classes of interest and the biological system under investigation.  
 
 Use of biphasic solvent systems such as methanol/chloroform/water mixtures offers several unique advantages 
over monophasic solvent systems. With such systems, the aqueous methanol-water phase can be used to extract polar 
metabolites, whilst the organic chloroform phase can be used to extract non-polar metabolites. Both the phases can be 
extracted simultaneously and each fraction can be analysed separately with better resolution, following centrifugation. In 
addition this method will avoid much of the variations caused by the analysis of both polar and non-polar metabolites 
from separate samples. The use of chloroform in biphasic solvent systems, ensures denaturation of enzymes, thereby 
halting the metabolism and preventing further degradation or interconversion of metabolites [32]. However, 
implementing these procedures is time consuming, difficult to automate thereby decreasing the scope for high-throughput 
analyses, and overall less suitable for metabolomics investigations. Moreover considerable loss of metabolites might 
occur [33], as some of the metabolites might be associated/leftover with the cell debris, which is usually located at the 
interphase between the polar and non-polar solvents. 
 
 For the unbiased analysis of metabolites it is essential that all metabolites need to be completely, non-selectively 
and reproducibly extracted by avoiding their degradation and/or conversion to other metabolites. Moreover, the resulting 
sample matrix should be compatible or amenable to the analytical method of choice. Till date, it has not been possible to 
generate such an extraction solvent. Completeness of extraction cannot be determined theoretically, as no one knows 
initially the number of metabolites present in the cells, hence determining the extent of metabolite degradation and 
efficacy of method should be tested to validate the optimal method. Efficacy can be tested by comparing the different 
methods for identical biological samples, whereas extent of metabolite degradation and the absence of enzyme activity 
can be tested by metabolite recoveries, by introducing an isotopically labelled analogue into the extraction solvent. In 
addition, evaluation based on qualitative (number of peaks) or semi-quantitative manner (peak area or height, normalised 
LQWHQVLWLHVZRQ¶WEHLGHDODVERWKDSSURDFKHVZRUNXQGer the assumption of linearity of response and absence of matrix 
effects, which is often not valid for complex cell extracts. 
 
3.2.4 Derivatization in GC-MS 
 The two-step derivatization procedure (methoximation followed by silylation with MSTFA) is most commonly 
used for GC-MS metabolite profiling. However, this method suffers from double derivatization of primary amines, which 
results in multiple chromatographic peaks that complicate the quantification of metabolites [34]. In addition, determining 
the optimal duration and temperature for this method is of great significance for quantitative metabolomics. In microbial 
metabolomics, a set of n-alkanes has been used [34] to calculate the derivatization efficiency, where the researchers 
evaluated several parameters such as choice of derivatization solvents, use of various oximation and silylation reagents, 
derivatization times and temperature. Moreover, in view of analytical performance of different metabolites which is 
mainly governed by the stability of the silylation product, authors classified metabolites based on their derivatization 
efficiencies. In another study [35], influence of storage temperature and duration on stability of the TMS derivatives was 
evaluated in quantifying 28 standard metabolites. Authors recommended -20°C is suitable temperature for stability of 
TMS derivatives under storage and that analysis should be carried out within 72h. 
 
 The sources of bias in GC-MS based metabolomics can occur in two forms (types A & B). Type A bias is 
universal and affects all the metabolites equally. It can be corrected by the addition of an IS, whereas type B bias affects 
individual metabolites differently. It has been pointed out [36] that the primary source of bias in GC-MS is the sample 
derivatization step, which introduces both Type A and to a greater extent Type B bias. In order to avoid the time 
dependent bias in derivatization, the use of automated in line derivatization has been proposed [37]. Alternatively, use of 
labelled metabolite standards or extracts from organisms (grown on labelled carbon source) has been proposed to 
calculate derivatization efficiency [4]. However, this approach is very expensive, increases complexity of the 
deconvolution process, does not address the issue of multiple derivatized peaks for the same metabolite and cannot be 
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applied to biological systems which are difficult to grow in vitro. An alternative solution to this has been proposed [24], 
where the use of isotopically labelled methyl chloroformate derivatization has been advocated. This approach was 
demonstrated for only two metabolite classes, and requires evaluation and validation of its applicability to quantify other 
metabolite classes as well. 
 
 In summary, sufficient derivatizing reagent and optimum conditions are essential for the efficient derivatization 
of all intracellular metabolites, as incomplete derivatization of compound with multiple functional groups may result in 
eluting multiple peaks for the same metabolite. Moreover, the stability of the derivatized extract and metabolite 
degradation during storage or their decomposition in the analytical system requires careful evaluation and validation in 
different matrices prior to quantification of metabolites.  
 
3.3 Challenges with the analytical platform 
 The choice of analytical platform can have great influence on quantitative data obtained in metabolomics 
experiments.  
 
3.3.1 High resolution mass spectrometry (HRMS) 
 Over the last decade, MS has secured a pinnacle position and holds additional promise for the advancement of 
quantitative metabolomics based on sensitivity, selectivity, relative cost and depth of coverage. Ionization methods in MS 
are classified on the basis of the source of the ions. The electron impact (EI) ionization and chemical ionization methods 
employ gas-phase sources and can be easily coupled with GC, but not with LC. In desorption methods, the sample in 
either gas or liquid state is converted to gaseous ions and is applicable to analysis of much higher masses e.g. MALDI 
and SALDI [38]. Lastly, the spray sources involve ionization of an aerosolized spray, such as atmospheric pressure 
chemical ionization (APCI) and electrospray ionization (ESI).  
 
 Mass analysers with different resolving powers are widely used in metabolomics. FTICR mass spectrometers are 
well known to provide higher mass accuracy (<1 ppm) and ultrahigh mass resolution (>1,000,000), but they are very 
expensive. Q-TOF instruments serve as a cheaper alternative and are capable of providing reasonable mass accuracy, 
sensitivity and dynamic range [39]. Alternatively, the Orbitrap analyzer uses an electrostatic field to trap ions and has 
excellent mass accuracy (1-5 ppm) and high resolving power (240,000) [40]. The TOF mass analyzers provides greater 
sensitivity by detecting all ions simultaneously (high acquisition rates >100Hz) rather than scanning mass ranges as is the 
case with many quadrupole instruments. In addition they provide accurate mass measurement of the molecular ion, with 
typical mass accuracies of <5 ppm and require no prior knowledge of the metabolites to be detected, as would be required 
for quadrupole DQGWULSOHTXDGUXSROH,QDVLQJOHVDPSOHUXQWKHDERYHPHQWLRQHG+506¶VFDQSURYLGHGLUHFWVWUXFWXUDO
information from the exact mass (up to level of structural isomers) and the resulting elemental composition of the analyte. 
Moreover, HRMS can accurately quantify many metabolites within a broad concentration range compared to MRM 
method. Q-exactive MS is an improved version of HRMS which offers excellent detection range as it can be operated by 
switching between positive and negative modes with sufficiently fast cycle times [41]. 
 
3.3.2 Hyphenated MS platforms 
 Direct MS analysis has been used in the past for many quantitative analyses, however it suffers from 
disadvantages such as ion suppression effects, inability to differentiate isomers and challenges in data interpretation as 
unique metabolite ions are difficult to distinguish from adduct and product ions [42]. Therefore, coupling of high-
resolution separations (GC, LC or CE) to MS is often essential for accurate quantification of metabolites [43].  
 
 GC-MS combines the high separation efficiency of capillary GC with the high sensitivity and resolution of MS. 
A wide range of volatile and/or derivatized non-volatile metabolites can be analyzed qualitatively and quantitatively with 
high analytical reproducibility and at lower costs compared to LC-MS and CE-MS. GC-MS with EI ionisation provides 
high sensitivity, wide dynamic range and results in production of reproducible spectra and highly transferable EI-MS 
spectral libraries that allows compound identification through mass spectral library matching. However, single 
quadrupole mass analysers have nominal mass accuracy and slow scan speed as opposed to QQQ mass analysers. With 
the use of GC-MS/MS, quadrupole scan speed of up to 20,000 mass units/second can be achieved, which offers the 
possibility of direct quantification [44]. Alternatively GC-TOF-MS offers higher mass accuracy, scan speed and 
resolution, essential for adequate sampling of high-resolution chromatographic peak widths in the range of 0.5-1s which 
also facilitates the implementation of fast GC methods, thus reducing the analysis time and increases the productivity. For 
complex biological samples, peak capacities, resolving power and depth of metabolome coverage can be further increased 
by the use of 2D-GC (GCxGC) that utilizes two columns having different stationary phase selectivities and are connected 
serially. Therefore, two metabolites of similar volatility but different polarity can be separated. In order to acquire 
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sufficient data points across the sharp narrow peaks, 2D-GC, is often coupled with TOF-MS. However, the data generated 
by GCxGC-TOF-MS is large and complex. The recently introduced GC/Q-Orbitrap-MS offers both performance 
characteristics of Orbitrap and quadrupole based isolation for sensitive analyte detection. In addition it also offers 
numerous analysis modalities (molecular ion directed acquisition (MIDA)) to facilitate structural elucidation [45], ideal 
for quantitative metabolomics. 
 
 The LC-MS platform offers several advantages over GC-MS, such as operation at lower temperature and does 
not require chemical derivatization, thus simplifying the sample preparation steps and identification of the metabolites. 
Detection in both the positive and negative ion mode simultaneously is possible with LC-MS, thus reducing the time 
required for analysis and reduce bias due to injection errors. The implementation of 2D-LC-MS for metabolomics has 
lagged behind that of 2D-GC-MS, due to a complicated experimental set-up and loss of sensitivity due to a sample 
dilution effect in the second dimension [42]. However, the major disadvantage of LC-MS is ion suppression, which can 
be overcome to some extent by miniaturization of ESI to nanospray ionization [46]. Another issue is the contamination of 
the MS source and adduct formation (which have significant consequences on the robustness of the method) and the lack 
of transferable LC-MS libraries for metabolite identifications [47]. For accurate quantification of metabolites, it is 
essential to detect these artefacts, prior to normalization of the data. HILIC separations are the most suitable and are an 
attractive option for metabolomics. However, there are still many important classes of metabolites which are poorly 
resolved with HILIC. Therefore, development of a method which can effectively capture a majority of the metabolite 
classes for a non-targeted metabolomic studies would be beneficial. 
 
 In summary, it is also important to determine the optimum analytical factors for accurate quantification of 
metabolites [48]. Till date, there is no single analytical method suitable for detection of all the metabolite classes due to 
physicochemical diversity of the metabolites, therefore parallel application of optimised GC-MS and LC-MS workflows 
for a given organism would be needed.  
 
3.4 Challenges in quantitative data analysis 
 The resulting data burden arising from the complexity and richness of the metabolome is regarded as one of the 
major issues. GC-MS and/or LC-MS experiments can generate two general types of data or mass spectral tags: 1) parent 
mass + chromatographic retention time or 2) parent mass + fragment mass + chromatographic retention time. The 
identification of both known and unknown compounds is possible if these properties are properly documented. The 
processing of raw chromatographic data involves a) spectral processing b) data analysis c) metabolite identification and 
quantification and d) biological interpretation. 
 
3.4.1 Spectral processing 
 Spectral processing involves accurate identification and quantification of the features in the raw spectral data, 
which is then arranged in a feature quantification matrix (FQM) for subsequent statistical data analysis. For further 
detailed information on spectral processing steps we recommend relevant review article [49]. For post-acquisition feature 
normalisation please refer to section 3.1.2.  
 
 Quantitative analysis is often challenging as multiple ions may correspond to different fragments from the same 
molecule, which requires deconvolution methods to assign different ions to the same metabolite. AMDIS, is the most 
promising deconvolution tool for GC-MS, as it can handle huge datasets, has automated processing and provides just one 
quantitative value per metabolite per sample. However, AMDIS is not compatible with LC-MS or CE-MS, but ESI-LC-
MS data can be processed using component detection algorithm. Later freely available software tools have been 
developed for backfilling missing values obtained from AMDIS-processed GC-MS spectra, producing a data matrix more 
suitable for subsequent chemometric analysis [50]. In GCxGC-MS analyses, two alternative software platforms 
ChromaTOF and parallel factor analysis (PARAFAC) have been used in the past. In the context of quantitation for non-
targeted metabolomics, the precision of these deconvolution tools are still lower compared to targeted approaches and 
require improvements.  
 
3.4.2 Data analysis, metabolite identification and spectral databases 
 Once raw data has been converted to a quantitative description (FQM), one can, in principle apply chemometric 
tools. The selection of multivariate analysis in metabolomics is highly dependent on the aim of the study. To define the 
metabolome more comprehensively via identification of metabolites, it is essential to construct appropriate mass spectral 
libraries and metabolite databases in order to extract the biological information from the data. Yi et al. [51] have provided 
an extensive review on this aspect, which the readers are referred to. 
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3.4.3 Validation and quality control (QC) 
  Any quantitative metabolomic workflow ideally should include evaluation of validation parameters such as 
selectivity, calibration model (linearity and range), accuracy, precision (repeatability and intermediate precision), limits of 
quantification (LLOQ) and additional parameters such as LOD, recovery, reproducibility and robustness. These 
validation parameters can be assessed with the use of appropriate ISs as detailed in section 3.2.1. The use of isotopically 
labelled ISs for every metabolite might be the ideal requirement, but its application is dependent on availability and cost 
considerations. Moreover, the validation performed for one matrix may not be applicable in another, requiring validation 
to be performed for all the matrices of interest. The most feasible and straightforward approach suggested could be the 
use of selected isotopically labelled ISs representing different metabolite classes [23]. In the absence of ISs, the accuracy 
of the analytical method can be determined by determining recovery of the spiked isotopically labelled metabolites to the 
sample. The variable response of metabolites at particular concentration due to matrix effects can be corrected by 
determining the ratio of the response of metabolite spiked after extraction and the metabolites in a standard solution.  
 
 QC of the validated analytical method is essential in order to ensure the quality and reliability of the analytical 
data obtained, which can be achieved with the use of ESs, ISs or combination of both. A better approach could be the use 
of in vivo isotopically labelled microorganisms as ISs, where biological samples are grown on isotopically labelled 
substrates, resulting in labelling of all the intracellular metabolites. The extract obtained from such a setup can then be 
spiked to the extract obtained from non-labelled biological sample. In this way, isotopically labelled ISs can be made 
available for all intracellular metabolites, for their accurate and reliable quantification. This approach can only be valid, if 
the labelled substrates are available and to their highest labelling efficiency. Moreover, the retention behaviour of labelled 
and endogenous metabolite is very similar and when silylation is used, their mass spectra can contain many similar 
fragments, thereby making the data complicated and difficult to quantify. This limitation can be overcome by the use of 
HRMS such as LTQ Orbitrap as demonstrated in past while quantifying central carbon metabolites in Methylobacterium 
extorquens using isotope dilution mass spectrometry (IDMS) [52].  
 
4. Matrix effects and use of IDMS 
 The biggest bottleneck in quantitative metabolomics is the occurrence of matrix effects, which include  artefacts 
caused by a) contributions from the biological sample matrix, b) loss due to leakage, degradation or interconversion of 
metabolites during sample processing steps and c) instrument specific negative influences (such as ion suppression), 
which corrupts the quantification of metabolites. To account for these matrix effects a number of strategies have been 
suggested such as diluting the sample, using alternative extraction and/or derivatization procedures, cleaning the sample 
by additional chromatographic steps, and compensating the matrix effect by normalisation to an IS [48].  
 
 The evaluation of matrix effects using set of ISs on quantification of short chain fatty acids, monosaccharides 
and compounds containing amino group (not amino acids) in faecal water was studied using GC-MS [53]. Authors 
pointed out that the pH of the standards mixture is crucial, as pH invariably affects the volatility and solubility of the 
analytes of interest resulting in matrix effect. Alternatively, use of 13C-labelled IS at the beginning (after quenching) and 
at the end of sample processing (prior to analysis) has been demonstrated to account for the matrix effects and in 
determining the metabolite recoveries in yeast metabolome. ISs added at the beginning determines the efficacy of the 
extraction protocols and can be used to compensate for the losses (volume losses or partial degradation - not metabolite 
inter-conversion), whereas the IS added at the end of sample processing can be used to correct analytical artefacts caused 
by sample matrix effects [54]. Similarly, use of 13C-labelled IS along with GC-IDMS has been proposed to assess the 
biases (such as leakage and metabolite co-precipitation) related to cold methanol quenching [55]. 
 
 The presence of high amounts of co-eluents along with the analytes of interest or presence of salts result in ion 
suppression. Ion suppression in the sample matrix can be minimised by reducing salt concentration in the resulting 13C-
labelled cell extract by exchanging the cultivation medium prior to sampling. Moreover the labelled substrates are very 
expensive, requiring development of a small scale set up with the high yield of 13C-labelled metabolites as demonstrated 
with E. coli for accurate quantification of metabolites using LC-ESI-MS [56]. The authors evaluated the matrix effects 
using the standard addition method. U-13C-labelled IS and IDMS were also used to quantify amino acids, intermediates of 
the glycolysis, TCA and PPP pathways using LC-MS/MS and GC-MS while evaluating the quenching protocols in A. 
niger chemostat cultures [57]. Dual labelling of metabolites has also been proposed [58] to account for variations in 
derivatization efficiencies (in LC-MS platform) in different matrices and to eliminate the effect of different matrices on 
ESI. In another application [59], a quantitative LC-MS approach was developed based on IDMS to quantify siderophores 
in uropathogenic E. coli, where the authors demonstrated the advantages of using IDMS in both structural confirmation 
and MS-based quantification . 
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 Recently, strategies used to account for matrix effects such as external calibration, IDMS and standards addition 
with ISs were evaluated and compared, while quantifying selected intracellular metabolites in E. coli extract using 
HILIC-ESI-MS/MS [60]. The linearity and accuracy was found to be similar for all the three strategies. However, matrix 
effect was evaluated only in the context of chromatographic separation. Moreover the conclusions were drawn on analysis 
of specific set of metabolites which might not be valid for other metabolites in the intracellular pool.  
 
 So far, IDMS using HRMS coupled to GC or LC seems to be a gold standard for targeted quantitative 
metabolomics. IDMS is difficult to apply with low resolution MS. EI result in generation of large number of fragment 
ions, which requires accurate mass measurements in order to differentiate mass spectral peak pattern between normal and 
isotopically labelled metabolite. The low resolution MS (GC-EI-MS) with non-targeted tracer fate detection (NTFD) 
algorithm has been recently proposed [61] for isotopologue ratio normalisation, for the automated semi-quantitative 
analysis of both identified and unidentified metabolites relative to isotopically labelled cell extract. The authors also 
demonstrated the utilisation of labelled yeast extract as a reference for the mammalian metabolome, where complete 
stable isotope labelling is hard to achieve. 
 
5. Conclusions  
 
 MS based approaches have found wide-spread interest in quantitative metabolomics. Advances in MS 
techniques over the years have enabled constructive use of this technique in attempts to capture metabolomic changes in 
biological systems, quantitatively. Whilst the approach has evolved over the years, there are several challenges that 
remain in reproducibly capturing quantitative metabolomics changes that enable biological interpretations. Here we have 
reviewed some of these challenges in microbial and mammalian systems. There is an increasing drive towards 
standardised approaches within the metabolomics community, but with the burgeoning interest in deriving quantitative 
metabolomics data, it is imperative that the associated challenges at each step of the workflow be given due 
consideration, both in designing experiments and in interpreting the results. 
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